Dr. Daniel S. Goldenberg is group leader at the Gene Therapy Institute.
Dr. Goldenberg is studying the molecular and cellular mechanisms of liver regeneration and development of chronic inflammation - mediated hepatocellular carcinoma using mouse models.
his work resulted in determining of multiple regulatory mechanisms that govern the development of hepatocellular carcinoma on the background of chronic liver inflammation.
Currently, is research group is exploring regulation of the LINE-1 retro transposition in hepatocellular carcinoma by micro RNAs.